These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7696105)

  • 1. Renal function in Laron syndrome patients treated by insulin-like growth factor-I.
    Klinger B; Laron Z
    Pediatr Nephrol; 1994 Dec; 8(6):684-8. PubMed ID: 7696105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type).
    Walker JL; Van Wyk JJ; Underwood LE
    J Pediatr; 1992 Oct; 121(4):641-6. PubMed ID: 1403403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I treatment of adult patients with Laron syndrome: preliminary results.
    Laron Z; Klinger B
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):631-8. PubMed ID: 7530175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome).
    Laron Z; Klinger B; Silbergeld A
    J Pediatr Endocrinol Metab; 1999; 12(2):145-52. PubMed ID: 10392360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone on growth and blood urea levels in children with chronic renal failure.
    McMahon KA; Powell HR; Walker RG; Jones CL
    J Paediatr Child Health; 1994 Jun; 30(3):230-3. PubMed ID: 8074908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
    J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene.
    de Lacerda L; Carvalho JA; Stannard B; Werner H; Boguszewski MC; Sandrini R; Malozowski SN; Leroith D; Underwood LE
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):541-50. PubMed ID: 10594514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin.
    Gafny M; Silbergeld A; Klinger B; Wasserman M; Laron Z
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):169-75. PubMed ID: 7923821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
    Backeljauw PF; Underwood LE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.
    Maxwell H; Nair DR; Dalton RN; Rigden SP; Rees L
    Pediatr Nephrol; 1995 Aug; 9(4):458-63. PubMed ID: 7577409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure.
    Fervenza FC; Friedlaender MM; Ike JO; Rabkin R
    Ren Fail; 1998 Mar; 20(2):349-56. PubMed ID: 9574462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency.
    Thorén MC; Wivall-Helleryd IL; Blum WF; Hall KE
    Eur J Endocrinol; 1994 Jul; 131(1):33-40. PubMed ID: 7518727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three year IGF-I treatment of children with Laron syndrome.
    Klinger B; Laron Z
    J Pediatr Endocrinol Metab; 1995; 8(3):149-58. PubMed ID: 8521188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature.
    Bucuvalas JC; Horn JA; Carlsson L; Balistreri WF; Chernausek SD
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1477-82. PubMed ID: 8501153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from acute ischaemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-1.
    Clark R; Mortensen D; Rabkin R
    Clin Sci (Lond); 1994 Jun; 86(6):709-14. PubMed ID: 8062506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS).
    Eshet R; Klinger B; Silbergeld A; Laron Z
    Regul Pept; 1993 Oct; 48(1-2):233-9. PubMed ID: 8265812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased neutrophil insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced functional capacity in patients with untreated Laron syndrome.
    Bjerknes R; Vesterhus P; Aarskog D
    Eur J Endocrinol; 1997 Jan; 136(1):92-5. PubMed ID: 9037133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.